B BRAUN MEDICAL recalled 1,298,454 hemodialysis bloodlines on September 30, 2025. The recall results from the risk of micro-air bubbles due to damaged connectors. Patients should stop using the product immediately and follow the manufacturer’s instructions.
The potential for micro-air bubbles observed in the bloodline and air-in-line alarms due to damaged arterial and venous patient connectors.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact B BRAUN MEDICAL INC or your healthcare provider for instructions. Notification method: Letter
The recalled product is the Streamline Bloodline Set for Dialog, Model No. SL-2010M2096. The recall affects 1,298,454 units distributed nationwide in the U.S.
The recall addresses the potential for micro-air bubbles in the bloodline. These bubbles can cause air-in-line alarms, posing a serious risk to patient safety.
No specific incidents or injuries have been reported related to this recall, although the hazard level is classified as high.
Patients and healthcare providers must stop using the device immediately. Contact B BRAUN MEDICAL INC or your healthcare provider for further instructions.
For further assistance, contact B BRAUN MEDICAL INC at their official website or through the recall notification letter.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.